The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and research expertise to lead the world in developing and advancing impactful cell therapies for patients in need.
AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients – Biotech Investments
EQS-News: AiCuris Anti-infective Cures AG / Key word(s): Miscellaneous AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for